Hepatitis E is a global health problem with about 20 million cases occurring annually, three million symptomatic cases, and ...

Long COVID is associated with active inflammatory changes in the nervous system, but the condition is distinct from Alzheimer ...

A study in eBioMedicine identifies shared immunopathology between SARS-CoV-2 infection and MDA5 autoimmunity, highlighting a ...

Influenza A virus (IAV), a negative-stranded RNA virus containing eight single-stranded RNA segments, belongs to the orthomyxoviridae family and can infect birds, humans, and other mammals. Indeed, ...

The top five common respiratory diseases in the world are diverse in their causes and treatments but share the common impact ...

Study to evaluate clinical effectiveness of low-dose oral interferons in treating chronic gingivostomatitis in cats, building upon VELDONA's history in animal health since 1985Clinical trials are ...

Resolve Therapeutics, a mid-stage clinical development company pioneering transformative therapies for autoimmune and post-viral illnesses, today announced the publication of its phase 2 long COVID ...

Proof-of-concept study for Imunon’s first vaccine utilizing its proprietary PlaCCine platform is now open for enrollmentTopline results expected ...

QIAGEN (QGEN) receives FDA clearance for the QIAstat-Dx respiratory syndromic testing panel for fast and accurate results.

Conference Call Begins Today at 11:00 a.m. Eastern TimeLAWRENCEVILLE, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a ...

The World Health Organization recently announced an outbreak of hepatitis E in the eastern Ouaddai province of Chad. Between January and April 2024, 2,093 suspected hepatitis E cases were reported ...